Effects of a pro-resolving drug in COVID-19: preclinical studies to a randomized, placebo-controlled, phase Ib/IIa trial in hospitalized patients.

Autor: Almeida PRJ; Center for Advanced and Innovative Therapies, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Periard AM; Center for Advanced and Innovative Therapies, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Tana FL; Center for Advanced and Innovative Therapies, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Avila RE; Hospital Eduardo de Menezes, Belo Horizonte, Brazil., Milhorato LB; Center for Advanced and Innovative Therapies, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Alcantara KMM; Center for Advanced and Innovative Therapies, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Resende CB; Center for Advanced and Innovative Therapies, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Serufo AV; Center for Advanced and Innovative Therapies, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Santos FR; Center for Advanced and Innovative Therapies, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Teixeira DC; Center for Advanced and Innovative Therapies, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Queiroz-Junior CM; Center for Advanced and Innovative Therapies, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Fonseca TCM; Center for Advanced and Innovative Therapies, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Silva BLV; Center for Advanced and Innovative Therapies, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Costa VV; Center for Advanced and Innovative Therapies, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Souza RP; Genetics Department, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., Perretti M; William Harvey Research Institute, Queen Mary University of London, London, UK., Jonassen TEN; Synact Pharma Aps, Holte, Denmark and Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark., Teixeira MM; Center for Advanced and Innovative Therapies, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.; Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Publikováno v: British journal of pharmacology [Br J Pharmacol] 2024 Dec; Vol. 181 (23), pp. 4750-4765. Date of Electronic Publication: 2024 Aug 19.

Developmental studies of the sublingual and mandibular salivary glands in Japanese quails (Coturinx coturinx japonica).

Autor: Khalifa, Mahmoud Osman¹ (AUTHOR) mahmoud.othman@aswu.edu.eg, Abd-Elkareem, Mahmoud² (AUTHOR), Gaber, Wafaa³ (AUTHOR), Saleh, Abdelmohaimen Mostafa³ (AUTHOR)

Publikováno v: BMC Veterinary Research. 11/12/2024, Vol. 20 Issue 1, p1-14. 14p.

Ethical considerations of artificial insemination

Autor: Avila, RE, Samar, ME

Publikováno v: Journal of Venomous Animals and Toxins including Tropical Diseases, Volume: 17, Issue: 4, Pages: 362-363, Published: 2011

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______608::d8749b2bc8fc509c8a9b0fcff11f2451
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992011000400002&lng=en&tlng=en

Loss of ZNF451 mediates fibroblast activation and promotes lung fibrosis.

Autor: Peng, Hong¹ (AUTHOR), Zhang, Yu^2,3 (AUTHOR), Min, Jiali^2,3 (AUTHOR), Tan, Yuexin¹ (AUTHOR), Liu, Shanshan^2,3 (AUTHOR) lss0625@csu.edu.cn

Publikováno v: Respiratory Research. 4/10/2024, Vol. 25 Issue 1, p1-11. 11p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.